• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

献血后第一周铁补充对铁状态的影响。

Effect of iron supplementation on iron status during the first week after blood donation.

机构信息

Institute of Medicine, University of Bergen, Bergen, Norway.

出版信息

Vox Sang. 2010 Apr;98(3 Pt 1):e249-56. doi: 10.1111/j.1423-0410.2009.01270.x. Epub 2009 Oct 28.

DOI:10.1111/j.1423-0410.2009.01270.x
PMID:19874572
Abstract

INTRODUCTION

Frequent blood donations may lead to a negative iron balance. Iron depletion may be prevented by iron supplementation after whole blood donations. The aim of this study was to compare the short time changes in iron status after donation in two groups randomized to iron supplementation or no additional iron. A second objective was to evaluate the effect of iron supplementation in donors having HFE-variants compared to HFE wild types.

METHODS

Subjects of both genders (199 women, 200 men) were randomised to receive iron supplementation or no additional iron after donation. Iron status, defined by the concentration of haemoglobin, serum ferritin, soluble transferrin receptor, concentration of haemoglobin in reticulocytes (CHr) and percent hypochrome mature red blood cells, was determined at the start of donation and 8 +/- 2 days after donation. HFE genotyping was performed at reappearance.

RESULTS

There was a significant difference between the two study groups on all the iron status parameters. CHr was an efficient, early marker of ongoing synthesis of haemoglobin. Heterozygosity for the HFE variants C282Y and H63D had no statistically significant influence on the iron status. The donor's baseline serum ferritin value may be basis for an individual iron supplementation regimen, as donors with serum ferritin >50 microg/l do not seem to utilize the iron supplementation, but prefer endogenous iron to restore the loss of haemoglobin.

CONCLUSION

Iron supplementation had a significant positive impact on the restoration of iron status one week after donation.

摘要

简介

频繁献血可能导致铁元素的负平衡。全血捐献后补充铁元素可以预防缺铁。本研究的目的是比较两组随机接受铁补充或不补充铁的个体在捐献后短时间内铁状态的变化。第二个目的是评估铁补充对 HFE 变异体与 HFE 野生型供者的影响。

方法

本研究纳入了 199 名女性和 200 名男性,随机分为接受铁补充或不补充铁的两组。在捐献开始时和捐献后 8±2 天,通过血红蛋白浓度、血清铁蛋白、可溶性转铁蛋白受体、网织红细胞血红蛋白浓度(CHr)和低色素成熟红细胞百分比定义铁状态,并进行 HFE 基因分型。

结果

两组在所有铁状态参数上均存在显著差异。CHr 是正在合成血红蛋白的有效早期标志物。HFE 变异体 C282Y 和 H63D 的杂合性对铁状态没有统计学意义的影响。供者的基线血清铁蛋白值可能是个体铁补充方案的基础,因为血清铁蛋白>50μg/l 的供者似乎不利用铁补充,而是更喜欢内源性铁来恢复血红蛋白的损失。

结论

铁补充对捐献后一周内铁状态的恢复有显著的积极影响。

相似文献

1
Effect of iron supplementation on iron status during the first week after blood donation.献血后第一周铁补充对铁状态的影响。
Vox Sang. 2010 Apr;98(3 Pt 1):e249-56. doi: 10.1111/j.1423-0410.2009.01270.x. Epub 2009 Oct 28.
2
The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*.反复献血导致铁丢失个体的 HFE 突变对血红蛋白和铁状态的影响*。
Br J Haematol. 2012 Feb;156(3):388-401. doi: 10.1111/j.1365-2141.2011.08952.x. Epub 2011 Nov 25.
3
Blood donors with hereditary hemochromatosis.遗传性血色素沉着症献血者。
Transfusion. 2010 Aug;50(8):1787-93. doi: 10.1111/j.1537-2995.2010.02627.x. Epub 2010 Mar 12.
4
Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.转铁蛋白饱和度升高的意大利候选献血者中血色素沉着症基因的突变
Hematol J. 2003;4(6):436-40. doi: 10.1038/sj.thj.6200324.
5
Blood loss is a stronger predictor of iron status in men than C282Y heterozygosity or diet.对于男性而言,失血比C282Y杂合性或饮食更能预测铁状态。
J Am Coll Nutr. 2008 Feb;27(1):158-67. doi: 10.1080/07315724.2008.10719687.
6
Genotype screening for hereditary hemochromatosis among voluntary blood donors in Hungary.匈牙利自愿献血者中遗传性血色素沉着症的基因分型筛查。
Blood Cells Mol Dis. 2001 Jan-Feb;27(1):334-41. doi: 10.1006/bcmd.2001.0384.
7
A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.一项基于人群的研究:HFE基因C282Y和H63D突变对铁代谢的影响
Eur J Hum Genet. 2003 Mar;11(3):225-31. doi: 10.1038/sj.ejhg.5200955.
8
Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men.改变1294名丹麦男性中HFE变异体C282Y、H63D、S65C表型表达的外在因素
Ann Hematol. 2009 Oct;88(10):957-65. doi: 10.1007/s00277-009-0714-x. Epub 2009 Mar 7.
9
HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.德国首次献血者的HFE基因型与铁代谢参数——C282Y杂合子中转铁蛋白饱和度升高的证据
Z Gastroenterol. 2003 Nov;41(11):1069-76. doi: 10.1055/s-2003-44299.
10
Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.血清铁调素浓度:与健康男性的铁吸收无关;与携带HFE突变的男性、接受放血治疗的遗传性血色素沉着症患者或孕妇的铁状态无关。
Br J Nutr. 2007 Mar;97(3):544-9. doi: 10.1017/S0007114507336829.

引用本文的文献

1
The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial.静脉铁补充对非贫血缺铁的献血者疲劳和一般健康的影响:一项随机安慰剂对照优效性试验。
Sci Rep. 2020 Aug 26;10(1):14219. doi: 10.1038/s41598-020-71048-0.
2
A Randomized Control Study to Evaluate Effects of Short-term Oral Iron Supplementation in Regular Voluntary Blood Donors.一项评估短期口服铁补充剂对定期无偿献血者影响的随机对照研究。
Indian J Hematol Blood Transfus. 2016 Sep;32(3):299-306. doi: 10.1007/s12288-015-0561-y. Epub 2015 Jun 13.
3
Daily iron supplementation for improving anaemia, iron status and health in menstruating women.
每日补充铁剂以改善经期女性的贫血状况、铁营养状况及健康水平。
Cochrane Database Syst Rev. 2016 Apr 18;4(4):CD009747. doi: 10.1002/14651858.CD009747.pub2.
4
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors.口服或胃肠外补充铁剂以减少献血者的延期献血、缺铁和/或贫血。
Cochrane Database Syst Rev. 2014 Jul 3;2014(7):CD009532. doi: 10.1002/14651858.CD009532.pub2.
5
Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial.非贫血但缺铁的女性献血者铁治疗效果的临床评估:一项随机对照试验。
BMC Med. 2012 Jan 24;10:8. doi: 10.1186/1741-7015-10-8.